Descriptors and administrative fields exactly as published in the CMS HCPCS quarterly file.
Billing context: J-codes
Units are reported in multiples of the dosage in the code descriptor.
One HCPCS billing unit of J1805
10 MG
Medicare payment limit per unit (Q4 2026): $0.246
No published MUE for J1805. CMS keeps some MUE values confidential, so this does not mean there is no daily unit limit.
Medicare Part B drug payment limits per billing unit, by quarter, from the CMS payment limit (ASP) files.
Current Medicare Part B payment limit · Q4 2026
$0.246per 10 MG
Effective Oct 1, 2026 – Dec 31, 2026 · ASP methodology (per CMS file) · based on Q2 2026 ASP data · coinsurance 20.000%
| Quarter | Effective | Payment limit | Per (billing unit) | Coinsurance | Change | CMS notes |
|---|---|---|---|---|---|---|
| Q4 2026 | Oct 1, 2026 – Dec 31, 2026 | $0.246 | 10 MG | 20% | +7.0% | — |
| Q3 2026 | Jul 1, 2026 – Sep 30, 2026 | $0.230 | 10 MG | 20% | −2.5% | — |
| Q2 2026 |
Medicare hospital outpatient (OPPS) · Q4 2026
N Packaged: no separate payment
Washington Apple Health · professional claims
AAC = actual acquisition cost, based on NDC or invoice; BR = by report; NC = not covered; DC = not covered, see a different code; DP = covered under another program (see comments); PA = prior authorization; EPA = expedited prior authorization (see the billing guide); CPA = contractor prior authorization (Qualis). For professional claims; hospital-administered drugs are paid under HCA's outpatient (OPPS/EAPG) rules.
Packages CMS assigns to this code in its NDC–HCPCS crosswalks, with billable units per package. Only official crosswalk rows are shown.
| NDC (11-digit) | CMS drug name · labeler | Pkg size × qty | Units / item | Units / NDC | Derived $ / NDC | Crosswalk | Quarters | FDA listing |
|---|---|---|---|---|---|---|---|---|
| 70121-1716-07 | Esmolol HClAmneal Pharmaceuticals, LLC | 250 × 10 | 250 | 2,500 | $615.00 | ASP | Q3 2024 – Q4 2026 | ListedEsmolol Hydrochloride |
| 70121-1717-07 | Esmolol HClAmneal Pharmaceuticals, LLC | 100 × 10 | 200 | 2,000 | $492.00 | ASP | Q3 2024 – Q4 2026 | ListedEsmolol Hydrochloride |
| 10019-0055-61 | Brevibloc In NaclBaxter Healthcare Corporation | 250 × 1 | 250 | 250 | $61.50 | ASP | Q3 2023 – Q4 2026 | ListedBrevibloc |
| 10019-0075-87 | BreviblocBaxter Healthcare Corporation | 100 × 1 | 200 | 200 | $49.20 | ASP | Q3 2023 – Q4 2026 | ListedBrevibloc |
| 10019-0115-01 | BreviblocBaxter Healthcare Corporation | 10 × 25 | 10 | 250 | $61.50 | ASP | Q3 2023 – Q4 2026 | ListedBrevibloc |
| 10019-0120-01 | Esmolol HClBaxter Healthcare Corporation | 10 × 25 | 10 | 250 | $61.50 | ASP | Q3 2023 – Q4 2026 | ListedESMOLOL HYDROCHLORIDE |
| 10019-0666-10 | BreviblocBaxter Healthcare Corporation | 100 × 10 | 200 | 2,000 | $492.00 | ASP | Q3 2023 – Q4 2026 | ListedBrevibloc |
| 10019-0668-10 | BreviblocBaxter Healthcare Corporation | 100 × 10 | 200 | 2,000 | $492.00 | ASP | Q3 2023 – Q4 2026 | ListedBrevibloc |
| 10019-0670-10 | BreviblocBaxter Healthcare Corporation | 250 × 10 | 250 | 2,500 | $615.00 | ASP | Q3 2023 – Q4 2026 | ListedBrevibloc |
| 10019-0672-10 | BreviblocBaxter Healthcare Corporation | 250 × 10 | 250 | 2,500 | $615.00 | ASP | Q3 2023 – Q4 2026 | ListedBrevibloc |
| 55150-0194-10 | Esmolol HClEugia US LLC | 10 × 25 | 10 | 250 | $61.50 | ASP | Q3 2023 – Q4 2026 | ListedESMOLOL HYDROCHLORIDE |
| 55150-0420-10 | Esmolol HClEugia US LLC | 250 × 10 | 250 | 2,500 | $615.00 | ASP | Q3 2023 – Q4 2026 | ListedEsmolol Hydrochloride |
| 55150-0421-10 | Esmolol HClEugia US LLC | 100 × 10 | 200 | 2,000 | $492.00 | ASP | Q3 2023 – Q4 2026 | ListedEsmolol Hydrochloride |
| 63323-0652-10 | Esmolol HClFreseniUS Kabi USA, LLC | 10 × 25 | 10 | 250 | $61.50 | ASP | Q3 2023 – Q4 2026 | ListedESMOLOL HYDROCHLORIDE |
| 00404-9785-10 | Esmolol HClHenry Schein Inc. | 10 × 1 | 10 | 10 | $2.46 | ASP | Q4 2025 – Q4 2026 | ListedESMOLOL HYDROCHLORIDE |
| 00404-9825-10 | BreviblocHenry Schein Inc. | 10 × 1 | 10 | 10 | $2.46 | ASP | Q3 2023 – Q4 2026 | ListedBrevibloc |
| 00404-9858-10 | Esmolol HClHenry Schein Inc. | 10 × 1 | 10 | 10 | $2.46 | ASP | Q3 2023 – Q4 2026 | ListedESMOLOL HYDROCHLORIDE |
| 51662-1444-01 | Esmolol HClHF Acquisition Co. LLC, DBA HealthFirst | 10 × 1 | 10 | 10 | $2.46 | ASP | Q4 2023 – Q4 2026 | ListedESMOLOL HYDROCHLORIDE |
| 51662-1444-03 | Esmolol HClHF Acquisition Co. LLC, DBA HealthFirst | 10 × 25 | 10 | 250 | $61.50 | ASP | Q4 2023 – Q4 2026 | ListedESMOLOL HYDROCHLORIDE |
| 67457-0182-10 | Esmolol HClMylan Institutional LLC | 10 × 10 | 10 | 100 | $24.60 | ASP | Q3 2023 – Q4 2026 | ListedESMOLOL HYDROCHLORIDE |
| 67457-0657-25 | Esmolol HClMylan Institutional LLC | 250 × 10 | 250 | 2,500 | $615.00 | ASP | Q3 2023 – Q4 2026 | ListedEsmolol hydrochloride in sodium chloride |
| 67457-0658-10 | Esmolol HClMylan Institutional LLC | 100 × 10 | 200 | 2,000 | $492.00 | ASP | Q3 2023 – Q4 2026 | ListedEsmolol hydrochloride in sodium chloride |
| 25021-0308-84 | Esmolol HClSagent Pharmaceuticals | 250 × 10 | 250 | 2,500 | $615.00 | ASP | Q3 2023 – Q4 2026 | ListedESMOLOL HYDROCHLORIDE |
| 25021-0309-82 | Esmolol HClSagent Pharmaceuticals | 100 × 10 | 200 | 2,000 | $492.00 | ASP | Q3 2023 – Q4 2026 | ListedESMOLOL HYDROCHLORIDE |
| 25021-0314-10 | Esmolol HClSagent Pharmaceuticals | 10 × 10 | 10 | 100 | $24.60 | ASP | Q3 2023 – Q4 2026 | Excluded listingesmolol hydrochloride |
| 44567-0450-10 | Esmolol HClWG Critical Care, LLC | 250 × 10 | 250 | 2,500 | $615.00 | ASP | Q4 2023 – Q4 2026 | ListedEsmolol Hydrochloride |
| 44567-0451-10 | Esmolol HClWG Critical Care, LLC | 100 × 10 | 200 | 2,000 | $492.00 | ASP | Q4 2023 – Q4 2026 | ListedEsmolol Hydrochloride |
Derived calculation “Derived $ / NDC” = billable units per NDC × the current payment limit. It is arithmetic for orientation, not a payment amount.
| NDC (11-digit) | CMS drug name · labeler | Pkg size × qty | Units / item | Units / NDC | Crosswalk | Quarters | FDA listing |
|---|---|---|---|---|---|---|---|
| 52584-0115-39 | BreviblocHenry Schein Inc. | 10 × 1 | 10 | 10 | ASP | Q3 2023 – Q1 2025Not in Q4 2026 file |
Medicare coverage is set nationally (NCDs) and by each Medicare Administrative Contractor (LCDs and Billing & Coding articles). These links open the official documents.
Verification neededCodeRx links to coverage documents instead of copying them: CMS distributes their code lists under AMA, ADA, and AHA license terms that limit reuse. Medicare Advantage, Medicaid, and commercial plans set their own coverage and prior-authorization rules.
Changes detected between the CMS quarterly HCPCS files CodeRx has imported.
| Quarterly file | Change | CMS action code | Details |
|---|---|---|---|
| Q1 2024 | Dates changed | P — Payment change | Added Jul 1, 2023 · action effective Jan 1, 2024 · termination — |
| Q3 2023 | Added to HCPCS | A — Added | Added date Jul 1, 2023 |
All imported releases, checksums, and import reports are listed on the data sources page.
Disclaimer. This application provides informational coding and reimbursement reference data. It does not constitute legal, clinical, coding, or billing advice. Codes, payment amounts, payer rules, and coverage policies can change. Verify all information with current CMS publications, the applicable payer, and your organization’s compliance policies before submitting a claim. CodeRx is not affiliated with or endorsed by CMS, FDA, Medicare, or any payer.
| Apr 1, 2026 – Jun 30, 2026 |
| $0.236 |
| 10 MG |
| 20% |
| +11.3% |
| — |
| Q1 2026 | Jan 1, 2026 – Mar 31, 2026 | $0.212 | 10 MG | 20% | −2.8% | — |
|---|
| Q4 2025 | Oct 1, 2025 – Dec 31, 2025 | $0.218 | 10 MG | 20% | −22.7% | — |
|---|
| Q3 2025 | Jul 1, 2025 – Sep 30, 2025 | $0.282 | 10 MG | 20% | +0.0% | — |
|---|
| Q2 2025 | Apr 1, 2025 – Jun 30, 2025 | $0.282 | 10 MG | 20% | +33.6% | — |
|---|
| Q1 2025 | Jan 1, 2025 – Mar 31, 2025 | $0.211 | 10 MG | 20% | +8.8% | — |
|---|
| Q4 2024 | Oct 1, 2024 – Dec 31, 2024 | $0.194 | 10 MG | 20% | −26.5% | — |
|---|
| Q3 2024 | Jul 1, 2024 – Sep 30, 2024 | $0.264 | 10 MG | 20% | +19.5% | — |
|---|
| Q2 2024 | Apr 1, 2024 – Jun 30, 2024 | $0.221 | 10 MG | 20% | −15.0% | — |
|---|
| Q1 2024 | Jan 1, 2024 – Mar 31, 2024 | $0.260 | 10 MG | 20% | +6.1% | — |
|---|
| Q4 2023 | Oct 1, 2023 – Dec 31, 2023 | $0.245 | 10 MG | 20% | −2.0% | — |
|---|
| Q3 2023 | Jul 1, 2023 – Sep 30, 2023 | $0.250 | 10 MG | 20% | — | Added July 2023 |
|---|